Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Liver Diseases |
Free Subscription
2 Am J Gastroenterol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Liver Diseases is free of charge.
From Shadows to Spotlight: Exploring the Escalating Burden of Alcohol-Associated
Liver Disease and Alcohol Use Disorder in Young Women.
Am J Gastroenterol. 2024;119:893-909.
PubMed
Abstract available
Is Hepatic Encephalopathy the First True Disorder of Gut-Brain interaction?
Am J Gastroenterol. 2024 Apr 22. doi: 10.14309/ajg.0000000000002824.
PubMed
Modulating PCGF4 Stability Is an Efficient Metastasis-Regulatory Strategy Used by
Distinct Subtypes of Cancer-Associated Fibroblasts in Intrahepatic
Cholangiocarcinoma.
Am J Pathol. 2024 Apr 24:S0002-9440(24)00160.
PubMed
Abstract available
Sarcopenic Obesity Promotes Recurrence in Patients Undergoing Resection for
Colorectal Liver Metastases (CRLM).
Anticancer Res. 2024;44:2177-2183.
PubMed
Abstract available
The Albumin-bilirubin Grade as Prognostic Indicator for Recurrent Hepatocellular
Carcinoma Needing Repeat Liver Resection.
Anticancer Res. 2024;44:2031-2038.
PubMed
Abstract available
Strategies to Perform Emergency Laparoscopic Partial Liver Resection for Ruptured
Hepatocellular Carcinoma.
Anticancer Res. 2024;44:2171-2176.
PubMed
Abstract available
Proton Beam Radiotherapy as a Curative Alternative to Radiofrequency Ablation for
Newly Diagnosed Hepatocellular Carcinoma.
Anticancer Res. 2024;44:2219-2230.
PubMed
Abstract available
Current Roles of Ramucirumab in the Sequential Treatment of Unresectable
Hepatocellular Carcinoma.
Anticancer Res. 2024;44:2055-2061.
PubMed
Abstract available
Long-term Outcomes of Hepatic Resection Combined With Intraoperative Ablation
Versus Hepatic Resection Alone for Multinodular Hepatocellular Carcinoma:
Insights from a Single-center Study.
Anticancer Res. 2024;44:2133-2140.
PubMed
Abstract available
Cold-shock Domain Protein A (CSDA) Influences Hepatocyte Growth Factor-medicated
Cell Proliferation and Metastasis in Gastric Cancer Cells.
Anticancer Res. 2024;44:1973-1981.
PubMed
Abstract available
Investigation of folate-modified EGCG-loaded thermosensitive nanospheres inducing
immunogenic cell death and damage-associated molecular patterns in hepatocellular
carcinoma.
Biochem Biophys Res Commun. 2024;714:149976.
PubMed
Abstract available
Acesulfame potassium upregulates PD-L1 in HCC cells by attenuating autophagic
degradation.
Biochem Biophys Res Commun. 2024;711:149921.
PubMed
Abstract available
Overexpression of Slc22a18 facilitates fat accumulation in mice.
Biochem Biophys Res Commun. 2024;712-713:149922.
PubMed
Abstract available
Non-small cell lung cancer and immune checkpoint inhibitor therapy: does
non-alcoholic fatty liver disease have an effect?
BMC Cancer. 2024;24:535.
PubMed
Abstract available
Prognostic value of creatine kinase (CK)-MB to total-CK ratio in colorectal
cancer patients after curative resection.
BMC Cancer. 2024;24:543.
PubMed
Abstract available
Ethanol responsive lnc171 promotes migration and invasion of HCC cells via
mir-873-5p/ZEB1 axis.
BMC Cancer. 2024;24:550.
PubMed
Abstract available
Analysis of Tumor-Associated AXIN1 Missense Mutations Identifies Variants That
Activate beta-Catenin Signaling.
Cancer Res. 2024;84:1443-1459.
PubMed
Abstract available
Impact of Cirrhosis Etiology on the Risk for Venous Thromboembolism.
Dig Dis Sci. 2024 May 3. doi: 10.1007/s10620-024-08440.
PubMed
Abstract available
An Electronic Health Record Model for Predicting Risk of Hepatic Fibrosis in
Primary Care Patients.
Dig Dis Sci. 2024 May 3. doi: 10.1007/s10620-024-08437.
PubMed
Abstract available
Association of GLP-1 receptor agonists and hepatocellular carcinoma incidence and
hepatic decompensation in patients with type 2 diabetes.
Gastroenterology. 2024 Apr 29:S0016-5085(24)00494.
PubMed
Abstract available
TLR8 agonist selgantolimod regulates Kupffer cell differentiation status and
impairs HBV entry into hepatocytes via an IL-6-dependent mechanism.
Gut. 2024 May 2:gutjnl-2023-331396. doi: 10.1136/gutjnl-2023-331396.
PubMed
Abstract available
Targeting hepatic stellate cells to combat liver fibrosis: where do we stand?
Gut. 2024 Apr 25:gutjnl-2023-331785. doi: 10.1136/gutjnl-2023-331785.
PubMed
Letter to Editor: Tranexamic acid in upper gastrointestinal bleed in patients
with cirrhosis - a randomized controlled trial.
Hepatology. 2024 Apr 29. doi: 10.1097/HEP.0000000000000915.
PubMed
Macrophage hitchhiking for systematic suppression in postablative multifocal
hepatocellular carcinoma.
Hepatology. 2024 Apr 29. doi: 10.1097/HEP.0000000000000903.
PubMed
Abstract available
Abdominal surgery in patients with chronic noncirrhotic extra hepatic portal vein
obstruction: A multicenter retrospective study.
Hepatology. 2024 Apr 29. doi: 10.1097/HEP.0000000000000901.
PubMed
Abstract available
Reply: Tranexamic acid in upper gastrointestinal bleed in patients with cirrhosis
- A randomized controlled trial.
Hepatology. 2024 Apr 30. doi: 10.1097/HEP.0000000000000916.
PubMed
Postoperative adjuvant chemotherapy is important for improving long-term survival
in patients with colorectal cancer liver metastases undergoing simultaneous
resection.
J Gastroenterol Hepatol. 2024;39:908-919.
PubMed
Abstract available
Mendelian-randomization study revealed causal relationship between nonalcoholic
fatty liver disease and osteoporosis/fractures.
J Gastroenterol Hepatol. 2024;39:847-857.
PubMed
Abstract available
Circulating leptin in patients with nonalcoholic fatty liver disease-related
liver fibrosis: a systematic review and a meta-analysis.
J Gastroenterol Hepatol. 2024;39:806-817.
PubMed
Abstract available
Positive impact of obesity on the prognosis of liver cirrhosis.
J Gastroenterol Hepatol. 2024 May 3. doi: 10.1111/jgh.16590.
PubMed
Abstract available
Dynamic liver volume change in predicting hepatic decompensation and long-term
effects of stereotactic body radiation therapy.
J Gastroenterol Hepatol. 2024 May 2. doi: 10.1111/jgh.16588.
PubMed
Abstract available
Performance of MAST, FAST, and MEFIB in predicting metabolic
dysfunction-associated steatohepatitis.
J Gastroenterol Hepatol. 2024 Apr 30. doi: 10.1111/jgh.16589.
PubMed
Abstract available
Role of hepatitis B core-related antigen in predicting the occurrence and
recurrence of hepatocellular carcinoma in patients with chronic hepatitis B: A
systemic review and meta-analysis.
J Gastroenterol Hepatol. 2024 Apr 30. doi: 10.1111/jgh.16558.
PubMed
Abstract available
Targeting EFHD2 Inhibits Interferon-gamma Signaling and Ameliorates Non-Alcoholic
Steatohepatitis.
J Hepatol. 2024 Apr 24:S0168-8278(24)00277-0. doi: 10.1016/j.jhep.2024.
PubMed
Abstract available
EVERY SHERIFF NEEDS A DEPUTY: TARGETING NON-PARENCHYMAL CELLS TO TREAT HEPATIC
FIBROSIS.
J Hepatol. 2024 Apr 25:S0168-8278(24)00283-6. doi: 10.1016/j.jhep.2024.
PubMed
Exploring Hepatocellular Carcinoma Risks in Sub-Saharan African and
Afro-Surinamese Individuals with Chronic Hepatitis B living in Europe.
J Hepatol. 2024 Apr 26:S0168-8278(24)00287-3. doi: 10.1016/j.jhep.2024.
PubMed
Recurrent splanchnic and extrasplanchnic thrombotic events in patients with
non-cirrhotic portal vein thrombosis associated with local factors.
J Hepatol. 2024 Apr 26:S0168-8278(24)00284-8. doi: 10.1016/j.jhep.2024.
PubMed
Abstract available
Nucleolin lactylation contributes to intrahepatic cholangiocarcinoma pathogenesis
via RNA splicing regulation of MADD.
J Hepatol. 2024 Apr 26:S0168-8278(24)00278-2. doi: 10.1016/j.jhep.2024.
PubMed
Abstract available
A Phase 3 Trial of Resmetirom in NASH with Liver Fibrosis. Reply.
N Engl J Med. 2024;390:1632-1633.
PubMed
A Phase 3 Trial of Resmetirom in NASH with Liver Fibrosis.
N Engl J Med. 2024;390:1632.
PubMed
Semaglutide combined with empagliflozin vs. monotherapy for non-alcoholic fatty
liver disease in type 2 diabetes: Study protocol for a randomized clinical trial.
PLoS One. 2024;19:e0302155.
PubMed
Abstract available
Upregulation of LHPP by saRNA inhibited hepatocellular cancer cell proliferation
and xenograft tumor growth.
PLoS One. 2024;19:e0299522.
PubMed
Abstract available
Evaluation of mucosal-associated invariant T-cells as a potential biomarker to
predict infection risk in liver cirrhosis.
PLoS One. 2024;19:e0294695.
PubMed
Abstract available
Usefulness of atezolizumab plus bevacizumab as second-line therapy for patients
with unresectable hepatocellular carcinoma.
PLoS One. 2024;19:e0298770.
PubMed
Abstract available
Super-Resolution US Imaging of Focal Nodular Hyperplasia.
Radiology. 2024;311:e233130.
PubMed
US-based Sequential Algorithm Integrating an AI Model for Advanced Liver Fibrosis
Screening.
Radiology. 2024;311:e231461.
PubMed
Abstract available
Protective Role of Rapamycin in Fibrotic Liver Ischemia/Reperfusion Injury
(C57bl/6 Mouse).
Transplant Proc. 2024;56:672-677.
PubMed
Abstract available
Beneficial Effect of Rapamycin on Liver Fibrosis in a Mouse Model (C57bl/6
Mouse).
Transplant Proc. 2024;56:701-704.
PubMed
Abstract available
Association of Abdominal Aortic Calcification With the Postoperative Metabolic
Syndrome Components After Liver Transplantation.
Transplant Proc. 2024 Feb 7:S0041-1345(24)00016.
PubMed
Abstract available
Liver Transplantation at a Small Volume Center-The Role of Network System.
Transplant Proc. 2024 Feb 5:S0041-1345(24)00037.
PubMed
Abstract available
Differential Effects of HDAC6 Inhibition Versus Knockout During Hepatic
Ischemia-reperfusion Injury Highlight Importance of HDAC6 C-terminal Zinc-finger
Ubiquitin-binding Domain.
Transplantation. 2024 Apr 30. doi: 10.1097/TP.0000000000005042.
PubMed
Abstract available
Thank you for your interest in scientific medicine.